New York and Brussels, December 10th, 2008 – Heartbeat Experts, the leading global provider of Key Opinion Leader (KOL) identification and consulting services, signed six new clients in the last two months, including two of the top ten pharmaceutical companies.
“Over the years, Heartbeat Experts has accumulated a wealth of experience in KOL Identification, especially for the Oncology market. The fact that we continue to win KOL projects in specialized therapeutic areas like Oncology solidifies our leading position in the marketplace and speaks to the quality of our processes, technology, and expert medical staff. We are especially proud that two of the top ten pharmaceutical companies have chosen to work with us on global KOL Identification projects,” stated Larry Cohen, EVP.
Kyu Om, Senior Director, Heartbeat Experts, added, “Given the intensely specialized nature of the Oncology business, our clients are looking for proven processes, proven expertise, and the ability to understand their science. These new projects combined with our existing track record in Oncology make Heartbeat Experts uniquely positioned in the Oncology market.”
“These projects combine peer to peer KOL interviews with analysis of publications, conference topics, and sentiment analyses to uncover the KOLs best suited for each of our client’s markets. We also employed state of the art KOL influence mapping and KOL segmentation to further analyze the data, providing our clients with rising stars and KOLs that are influential with guidelines committees,” stated Frank Vanderdonck, Senior Medical Manager.
Heartbeat Experts, with offices in five countries and expertise in twelve major therapeutic areas, is the leading provider of Key Opinion Leader Identification and consulting services. Heartbeat Experts works with fifteen of the top thirty pharmaceutical and biotech companies on KOL identification, KOL Segmentation, KOL Profiling, KOL Influence Mapping, and KOL Planning.
In today’s healthcare environment, life sciences companies face pricing, reimbursement, policy and regulatory challenges. In meeting these challenges…
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved